Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus.

Pharmacol Res

Henry Wellcome Laboratories for Integrative Neuroscience and Endocrinology, School of Clinical Sciences, Faculty of Health Sciences, University of Bristol, Whitson Street, Bristol, BS1 3NY, United Kingdom; Centre for Synaptic Plasticity, University of Bristol, Whitson Street, Bristol, BS1 3NY, United Kingdom. Electronic address:

Published: July 2017

Evidence suggests that the stress hormones glucocorticoids (GCs) can cause cognitive deficits and neurodegeneration. Previous studies have found GCs facilitate physiological synapse weakening, termed long-term depression (LTD), though the precise mechanisms underlying this are poorly understood. Here we show that GCs activate glycogen synthase kinase-3 (GSK-3), a kinase crucial to synapse weakening signals. Critically, this ultimately leads to phosphorylation of the microtubule associated protein tau, specifically at the serine 396 residue, and this is a causal factor in the GC-mediated impairment of synaptic function. These findings reveal the link between GCs and synapse weakening signals, and the potential for stress-induced priming of neurodegeneration. This could have important implications for our understanding of how stress can lead to neurodegenerative disease.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2017.04.015DOI Listing

Publication Analysis

Top Keywords

synapse weakening
16
weakening signals
8
glucocorticoids activate
4
synapse
4
activate synapse
4
weakening
4
weakening pathway
4
pathway culminating
4
culminating tau
4
tau phosphorylation
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!